Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on June 15, 2025
Dr. Kevin Sadati Present his Preservation Facelift Technique at Vegas Cosmetic Surgery and UC Irvine
EIN Presswire
·
June 15, 2025
“Preservation isn’t just a buzzword,” said Dr. Sadati. “It’s a guiding principle. NEWPORT BEACH, CA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- This week, facial plastic surgeon Dr. Kevin Sadati continued to gain national attention for his …
CPR Classes Near Me Brings Premier CPR and First Aid Training to the Philadelphia Area
EIN Presswire
·
June 15, 2025
LANSDALE, PA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- CPR Classes Near Me, a leading provider of certified CPR and First Aid training, has expanded into the Philadelphia region with the opening of a new training center located at 5 N Cannon …
CPR Classes Near Me Opens New Location in Miami Lakes to Serve Hialeah and Surrounding Areas
EIN Presswire
·
June 15, 2025
MIAMI LAKES, FL, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- CPR Classes Near Me, a nationally trusted provider of American Heart Association (AHA) CPR and First Aid certification, has opened its newest location at 6625 Miami Lakes Dr #101, Miami …
CPR Classes Near Me Launches 31st Location in Louisville, KY – Offering AHA Certification for Individuals and Businesses
EIN Presswire
·
June 15, 2025
LOUISVILLE, KY, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- CPR Classes Near Me, a national leader in CPR and First Aid certification, is proud to announce the opening of its 31st training center, now open in Louisville at 1860 Mellwood Ave. …
CPR Classes Near Me Expands to 32nd Location in Boston Area – Now Open in Needham, MA
EIN Presswire
·
June 15, 2025
NEEDHAM, MA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- CPR Classes Near Me, one of the nation’s fastest-growing providers of CPR and First Aid certification, is proud to announce the opening of its 32nd training center, now serving the Boston …
ClearView Imaging Center offering free heart scans
EIN Presswire
·
June 15, 2025
Free Heart Artery Calcium Score For All Patients THE VILLAGES, FL, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- ClearView Imaging Center is proud to announce the grand opening of its state-of-the-art diagnostic imaging facility at 3325 Wedgewood …
Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21
EIN Presswire
·
June 15, 2025
Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- In a time when public health and …
Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece
EIN Presswire
·
June 15, 2025
Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- Fabry Disease, a rare, X-linked …
Rewriting the Playbook in MPS I: CNS-Penetrant ERTs and Gene Therapies Usher in a New Treatment Era | CI Insights
EIN Presswire
·
June 15, 2025
Emerging CNS‑targeting ERTs and gene therapies for MPS I show promise for neurocognitive benefits, reduced treatment burden, and better outcomes. AUSTIN, TX, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- Mucopolysaccharidosis type I (MPS I) is an …
Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly
EIN Presswire
·
June 15, 2025
New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- Hunter Syndrome ( …
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
GlobeNewswire
·
June 15, 2025
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that results from 13 studies of its core …
Thorncrest Dental Brings Advanced Laser Dentistry to Etobicoke with Picasso Soft Tissue Laser
EIN Presswire
·
June 15, 2025
ETOBICOKE, ONTARIO, CANADA, June 15, 2025 /EINPresswire.com/ -- Thorncrest Dental is proud to introduce the Picasso Soft Tissue Laser, a cutting-edge addition to its suite of dental technologies, now available to patients in the Etobicoke community. This …
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
GlobeNewswire
·
June 15, 2025
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …
Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute 1ere étude respiratoire de ph4 en comparaison directe …
GlobeNewswire
·
June 15, 2025
EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …
Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial
GlobeNewswire
·
June 15, 2025
New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp …
Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices
EIN Presswire
·
June 15, 2025
New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- Tom Jackobs, international sales strategist, is now offering …
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress
GlobeNewswire
·
June 15, 2025
With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …
Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
GlobeNewswire
·
June 15, 2025
– Pharmacology modeling data presented at the European Academy of Allergy …
D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth
GlobeNewswire
·
June 15, 2025
Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced athletic performance and muscle growth, many fitness enthusiasts and bodybuilders turn to supplements. D-Bal Max has emerged as a noteworthy option that claims to replicate the muscle- …